Purpose

The proposed research is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in muscle strength, volume, fatigue resistance, and mobility in older adults after daily consumption of 12g of linoleic acid-rich oil.

Condition

Eligibility

Eligible Ages
Between 65 Years and 80 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Linoleic Acid Intake <75% of the adequate intake - Probable sarcopenia

Exclusion Criteria

  • Gastrointestinal diseases or disorders (including pancreatic and gastric bypass surgery) where consumption of the study foods would be contraindication or where the disease or disorder could negatively affect nutrient absorption and/or would prevent participants from tolerating the study foods - Hyperthyroidism diagnosis - Food Allergy or intolerances - Any dietary restriction where consumption of the study foods or any ingredient would be contraindicated - Unstable management of heart failure, heart disease events (including stroke or heart attack) within last 3 months prior to enrollment, a plan for heart surgeries or cardiac procedures - Current or previous diagnosis of severe kidney failure, liver cirrhosis, other liver diseases/infections that cause liver damage and some pulmonary diseases or severe/uncontrolled pulmonary diseases - Severe or uncontrolled rheumatologic or orthopedic diseases - Current diagnosis of or current treatment of cancer other than non-melanoma skin cancer - Neuromuscular or neurological conditions or diseases or use of mobility assistance (wheelchair, walker etc..) that would impact movement needed to perform the muscle function tests or prevent completion of the muscle function tests - Use of mobility assistance (wheelchair, walker etc..) that would prevent completion of the muscle function tests - Current use of supplements or medications for weight loss or following a weight loss program - Use of supplements high in linoleic acid in the past 4 weeks prior to enrolling - Pregnancy and lactation - Alcohol or drug abuse - Allergy/intolerance to lidocaine or similar medication - Use of anticoagulant, antiplatelet, or other blood thinner medications - Terminal Illness - Any condition leading to muscle loss or weakness, impaired mobility or range of motion in legs (excluding normal aging)

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
High Linoleic Safflower Oil
consumption of 12g of high linoleic safflower oil every day
  • Other: High Linoleic Acid Foods
    Two food products containing 6g of high linoleic safflower oil each will be consumed each day for a total of 12g daily
Placebo Comparator
High Oleic Safflower Oil
Consumption of 12g of high oleic safflower oil every day
  • Other: High Oleic Acid Foods
    Two food products containing 6g of high oleic safflower oil each will be consumed each day for a total of 12g daily

Recruiting Locations

The Ohio State University
Columbus 4509177, Ohio 5165418 43210
Contact:
Martha Belury, PhD
614-292-1680
belury.1@osu.edu

More Details

Status
Recruiting
Sponsor
Ohio State University

Study Contact

Martha Belury, PhD RDN
614-292-1680
belury.1@osu.edu

Detailed Description

Study Objectives 1. To assess the effect of linoleic acid supplementation on muscle strength, muscle volume, fatigue- resistance, and physical mobility. 2. To quantify the impact of linoleic acid supplementation on cardiolipin species and mitochondrial function in skeletal muscle of older adults

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.